JHP in Product Transfer Pact

JHP Pharmaceuticals has entered into an agreement with an undisclosed pharmaceutical company for the product transfer and registration batch production of a diagnostic aid.

Stuart Hinchen, president and chief executive officer of JHP, said, “Our record of cGMP compliance, coupled with comprehensive experience in manufacturing site transfers put us in the position to serve this important customer.”

He added, “Our Rochester, MI site has a 25-year history in contract manufacturing. Since purchasing the plant in 2007, we have focused on growing our internal infrastructure to support expansion of our contract manufacturing services by investing in both our people and our facilities.” Recent investments include a clinical filler and a 240-sq.-ft. lyophilizer in addition to expanding JHP’s Manufacturing, Regulatory and Quality Teams.